X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
IPCA Labs Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Quarterly Results   (IPLB)

Here are the latest quarterly results of IPCA Labs. For more details, see the IPCA Labs financial fact sheet and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

IPCA Labs Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m7,5807,4926,8416,2468,4228,8517,5076,658 
Other income Rs m4153508749625952 
Turnover Rs m7,6217,5456,8916,3338,4708,9137,5676,710 
Expenses Rs m6,8746,8395,9575,6397,2187,4926,4435,981 
Gross profit Rs m8228928845261,2041,3581,065677 
Depreciation Rs m421437448392422429432428 
Interest Rs m557091065685744 
Profit before tax Rs m388438394221766924636257 
Tax Rs m8282162156290374222-187 
Profit after tax Rs m30535623265476550414444 
Gross profit margin %10.811.912.98.414.315.314.210.2 
Effective tax rate %21.318.841.270.737.940.534.9-72.7 
Net profit margin %4.04.73.41.05.66.25.56.7 
Diluted EPS Rs 2.4 2.8 1.8 0.5 3.8 4.4 3.3 3.5  
Diluted EPS (TTM) Rs 11.0 8.2 5.9 7.6 8.9 10.5 11.9 14.9  
 Subscriber Feature View   View            
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Pharmaceuticals Company Quarterly Results:   ALEMBIC PHARMA  WYETH LTD  SANOFI INDIA  BIOCON LTD  VENUS REMEDIES  

Compare IPCA LABS With:   ALEMBIC PHARMA  WYETH LTD  SANOFI INDIA  BIOCON LTD  VENUS REMEDIES  

Compare IPCA LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Closes above 100 Points; IT & Realty Stocks Rally(Closing)

Indian share markets gathered some momentum in the afternoon session to finish above the dotted line amid firm global markets.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Why Merger of Public Sector Banks Continues to Be a Bad Idea(Vivek Kaul's Diary)

Oct 10, 2017

There is enough research evidence that suggests that most mergers don't work.

Electric Vehicles: The Final Piece of the Puzzle(Smart Contrarian)

Oct 16, 2017

Just as there would be gainers from an electric vehicles boom, who possibly could be the biggest losers.

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

Companies Are Wary of Borrowing(Chart Of The Day)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2018
Get our special report, Multibagger Stocks Guide (2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Oct 23, 2017 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS - ALEMBIC LTD COMPARISON

COMPARE IPCA LABS WITH

MARKET STATS